Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Novavax Inc (NQ: NVAX )

212.83 USD +4.68 (+2.25%)
Official Closing Price Updated: 7:59 PM EDT, Apr 21, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 2,450,600
Open 204.77
Bid (Size) 212.11 (12)
Ask (Size) 212.50 (4)
Prev. Close 208.15
Today's Range 200.78 - 217.21
52wk Range 16.41 - 331.68
Shares Outstanding 73,858,882
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
Novavax to Participate in University of Oxford Com-COV2 Study Comparing Mixed COVID-19 Vaccine Combinations
- Study to explore heterologous regimen of COVID-19 vaccines from different manufacturers 
From PR Newswire
Ocugen’s Outlook Is Still Very Bleak
InvestorPlace - Stock Market News, Stock Advice & Trading Tips The U.S. is likely to receive enough vaccines from its current partners, so OCGN stock will probably tumble over the longer term. The post... 
Tags JNJ OCGN INO
From InvestorPlace

Performance

YTD
+88.38%
+88.38%
1 Month
-10.27%
-10.27%
3 Month
+70.20%
+70.20%
6 Month
+133.47%
+133.47%
1 Year
+888.53%
+888.53%

More News

Read More
Notable Monday Option Activity: MAT, NVAX, X
Tags Stocks
From Market News Video
12 Health Care Stocks Moving In Monday's Intraday Session
Tags INMB EVAX FSTX
From Benzinga
Why Novavax Could Be the Biggest Winner From Johnson & Johnson's Vaccine Woes
Tags MRNA JNJ NVAX
From Motley Fool
Here’s What $1,000 Invested In Vaccine Stocks Would Be Worth Now
Tags Healthcare Market News Pharma/Biotech
From Blogs - TalkMarkets
The Moderna CEO's Bold Statement That May Mean Bad News for Novavax
Tags MRNA NVAX Market News
From Motley Fool
Notable ETF Outflow Detected - IWN, DAR, NVAX, CLF
Tags ETFs
From ETF Channel
Novavax Is Missing Out on a Big Deal
Tags Market News NVAX
From Motley Fool
AstraZeneca's Vaccine Data Is Still Good Enough for U.S. Authorization
Tags AZN NVAX Market News
From Motley Fool
3 Biotech Stocks Ripe for Spring Portfolio Cleaning
Tags BLUE NTLA FGEN
From Motley Fool
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.